[Ganglion curage in prostate cancer]

Area of Science:

• Urology
• Surgical Oncology

Context:

• Pelvic lymphadenectomy (PLND) in clinically localized prostate cancer is debated.
• PLND provides essential prognostic information (lymph node status, tumor volume, extracapsular extension) not available through other methods.
• Current decision-making relies on nomograms predicting low metastasis risk for specific PSA and Gleason scores, leading to controversy.

Purpose:

• To evaluate the role and extent of pelvic lymphadenectomy in localized prostate cancer.
• To address the lack of consensus regarding patient selection and surgical scope for PLND.
• To explore the potential therapeutic benefits of extended lymphadenectomy compared to standard procedures.

Summary:

• Standard PLND nomograms may lack precision and underestimate metastasis risk.
• Extended PLND may offer therapeutic advantages, analogous to its established role in other cancers (gastric, breast, colorectal, bladder).
• The prognostic value of PLND in prostate cancer warrants further investigation to refine surgical indications and extent.

Impact:

• Clarifying the indications and extent of PLND can improve staging accuracy and treatment planning for prostate cancer patients.
• Optimizing lymphadenectomy strategies may enhance survival and reduce recurrence rates.
• This research could lead to revised clinical guidelines for managing localized prostate cancer.